ArticleFrontiers in cardiovascular medicine2025

ECMO combined with IABP for the treatment of fulminant myocarditis caused by the targeted drug entrectinib for lung adenocarcinoma: a case report.

Qi Yujuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.